Is "gnbt"worth investing in now(May 2007) ?
$1.43. Not knowing when news announcements are to be,
I can't help feel it will go back under $1 dollar soon before any spectacular news announcements.
Sales,Profit margins, eps,volume, are not sufficient to invest in while waiting for me. Ratings are poor, and stock price is under 20,50, and 200 day moving average. Last upgrade
to buy was in 2001 ?
In evaluating a stock, what does an investor look for other than unknown approvals, otherwise everyone should just buy every biotech stock and throw them in a safety deposit box?
Answers:
If you were hunting ducks and spotted just one in the flock and weren't satisfied until you bagged only it--that is one way to describe hanging your biotech interests on only one company. If you lived in Ecuador and had diabetes and liked this product, then buy, buy, buy. If you merely had diabetes or were interested in something that addressed that market, then it is cheap enough to buy some and forget it. They have a product, they just have to prove it to the satisfaction of the US FDA, and then succeed in marketing it.
Until then, or some eventual good news, how about looking at DEPO or SPPI instead?
Without even knowing what that company is involve with, base from the info you gave, I should have get rid of it, upon noticing its earning is negative, buy back later when the same start turning around, i.e. if you're too sentimental.
Investing is not the way you described in your last paragraph. You have to watch for the financial statement the company releases. If it's earning money or losing money. If losing, why? Dig for the answer. Too much spent for research or too much went to CEO (and others) pockets. If the answer to why is not justified, get out of it.
Check out too whether the insiders are selling their own holdings of the stock. If they are, that's a very bad sign.
The answers post by the user, for information only, BAnswer.com does not guarantee the right.
More Related Questions and Answers...